Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02018263Phase 1Completed
Phase 1 trial (3 arms), sponsored by Yale University. Primary endpoint: Instantaneous Heart Rate and Heart Rate Variability at 4 weeks. Started Oct 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02018263.